Cardio Diagnostics (CDIO) Competitors $4.76 +0.34 (+7.69%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. MRNS, GRCE, CVKD, INKT, ALLK, OKUR, KZR, GBIO, SRZN, and CALCShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Marinus Pharmaceuticals (MRNS), Grace Therapeutics (GRCE), Cadrenal Therapeutics (CVKD), MiNK Therapeutics (INKT), Allakos (ALLK), OnKure Therapeutics (OKUR), Kezar Life Sciences (KZR), Generation Bio (GBIO), Surrozen (SRZN), and CalciMedica (CALC). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Marinus Pharmaceuticals Grace Therapeutics Cadrenal Therapeutics MiNK Therapeutics Allakos OnKure Therapeutics Kezar Life Sciences Generation Bio Surrozen CalciMedica Cardio Diagnostics (NASDAQ:CDIO) and Marinus Pharmaceuticals (NASDAQ:MRNS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and valuation. Does the MarketBeat Community prefer CDIO or MRNS? Marinus Pharmaceuticals received 433 more outperform votes than Cardio Diagnostics when rated by MarketBeat users. However, 80.00% of users gave Cardio Diagnostics an outperform vote while only 65.52% of users gave Marinus Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCardio DiagnosticsOutperform Votes480.00% Underperform Votes120.00% Marinus PharmaceuticalsOutperform Votes43765.52% Underperform Votes23034.48% Which has stronger valuation and earnings, CDIO or MRNS? Cardio Diagnostics has higher earnings, but lower revenue than Marinus Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardio Diagnostics$19.90K415.92-$8.38MN/AN/AMarinus Pharmaceuticals$30.99M0.98-$141.40M-$2.47-0.22 Do institutionals & insiders believe in CDIO or MRNS? 8.1% of Cardio Diagnostics shares are owned by institutional investors. Comparatively, 98.8% of Marinus Pharmaceuticals shares are owned by institutional investors. 22.3% of Cardio Diagnostics shares are owned by company insiders. Comparatively, 5.5% of Marinus Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is CDIO or MRNS more profitable? Marinus Pharmaceuticals has a net margin of -446.48% compared to Cardio Diagnostics' net margin of -22,732.03%. Cardio Diagnostics' return on equity of -258.85% beat Marinus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Cardio Diagnostics-22,732.03% -258.85% -191.20% Marinus Pharmaceuticals -446.48%-7,831.35%-120.74% Which has more volatility and risk, CDIO or MRNS? Cardio Diagnostics has a beta of 3.7, suggesting that its stock price is 270% more volatile than the S&P 500. Comparatively, Marinus Pharmaceuticals has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Do analysts recommend CDIO or MRNS? Cardio Diagnostics presently has a consensus price target of $60.00, suggesting a potential upside of 1,160.50%. Marinus Pharmaceuticals has a consensus price target of $4.79, suggesting a potential upside of 771.56%. Given Cardio Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Cardio Diagnostics is more favorable than Marinus Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Marinus Pharmaceuticals 0 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.40 Does the media refer more to CDIO or MRNS? In the previous week, Cardio Diagnostics had 2 more articles in the media than Marinus Pharmaceuticals. MarketBeat recorded 4 mentions for Cardio Diagnostics and 2 mentions for Marinus Pharmaceuticals. Marinus Pharmaceuticals' average media sentiment score of 0.00 beat Cardio Diagnostics' score of -0.50 indicating that Marinus Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardio Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Marinus Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCardio Diagnostics beats Marinus Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.69M$2.67B$5.42B$8.48BDividend YieldN/A0.75%5.22%4.11%P/E RatioN/A7.6626.8320.05Price / Sales415.9229.09393.90117.05Price / CashN/A15.7538.2534.62Price / Book34.005.846.874.61Net Income-$8.38M-$65.73M$3.22B$248.19M7 Day Performance5.08%5.72%6.76%2.97%1 Month Performance-57.12%8.36%13.66%16.58%1 Year Performance-77.33%-14.74%18.27%8.16% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics2.6074 of 5 stars$4.76+7.7%$60.00+1,160.5%-77.0%$7.69M$19,902.000.001News CoverageEarnings ReportHigh Trading VolumeMRNSMarinus Pharmaceuticals1.9145 of 5 stars$0.55-0.2%$4.79+771.6%-59.3%$30.32M$30.99M-0.22110News CoverageAnalyst ForecastGRCEGrace Therapeutics1.896 of 5 stars$2.99+6.8%$12.00+301.3%N/A$30.32MN/A-2.58N/AGap UpCVKDCadrenal Therapeutics2.5703 of 5 stars$15.35-1.0%$32.00+108.5%N/A$30.19MN/A-2.304News CoverageINKTMiNK Therapeutics2.6544 of 5 stars$7.60+0.8%$37.50+393.4%-26.1%$30.14MN/A-1.9530Earnings ReportAnalyst RevisionGap DownALLKAllakos4.2656 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190OKUROnKure Therapeutics2.9676 of 5 stars$2.20+10.0%$32.33+1,369.7%N/A$29.72MN/A-0.18N/ANews CoverageInsider TradeGap UpKZRKezar Life Sciences4.2224 of 5 stars$4.03-1.0%$39.50+880.1%-46.6%$29.44M$7M-0.3160Positive NewsGBIOGeneration Bio3.3331 of 5 stars$0.40+5.4%$7.33+1,725.1%-88.6%$26.94M$24.56M-0.18150SRZNSurrozen3.0433 of 5 stars$8.03+13.1%$38.50+379.5%-10.5%$26.35M$10.66M-0.3280CALCCalciMedica2.6218 of 5 stars$1.86-7.0%$18.00+867.7%-65.3%$25.99MN/A-1.7230Earnings Report Related Companies and Tools Related Companies MRNS Competitors GRCE Competitors CVKD Competitors INKT Competitors ALLK Competitors OKUR Competitors KZR Competitors GBIO Competitors SRZN Competitors CALC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDIO Stock Free CDIO Stock Alerts